The Innovation Center of NanoMedicine has summarized the results of its collaborative research with Professor Kanjiro Miyata's group from the Department of Materials Engineering/Bioengineering at the ...

The approach employed by the research team could be used against other diseases—including COVID-19 and influenza.

Blood cancer, which originates from irregular blood cell generation within the bone marrow, represents a serious health ...

Instead of extracting T-cells and engineering them in a lab, researchers have delivered mRNA directly into circulating immune ...

Blood cancer arises from abnormal blood cell production in the bone marrow, disrupting normal function. Early detection through regular check-ups is c ...

While data is promising, many questions remain about topics such as timing and doses in the treatment of hematologic malignancies.